PUS10
tRNA pseudouridine synthase Pus10
Also known as: CCDC139, FLJ32312, PUS10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3MIT2
- Gene
- PUS10
- Ensembl
- ENSG00000162927
- Chromosome
- 2
- Canonical length
- 529 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Mitochondria
OverviewNCBI Gene
Pseudouridination, the isomerization of uridine to pseudouridine, is the most common posttranscriptional nucleotide modification found in RNA and is essential for biologic functions such as spliceosome biogenesis. Pseudouridylate synthases, such as PUS10, catalyze pseudouridination of structural RNAs, including transfer, ribosomal, and splicing RNAs. These enzymes also act as RNA chaperones, facilitating the correct folding and assembly of tRNAs (McCleverty et al., 2007 [PubMed 17900615]).[supplied by OMIM, May 2009]
Canonical amino-acid sequenceUniProt
529 residues, UniProt reviewed canonical sequence.
>Q3MIT2|PUS10
1 MFPLTEENKH VAQLLLNTGT CPRCIFRFCG VDFHAPYKLP YKELLNELQK FLETEKDELI
61 LEVMNPPPKK IRLQELEDSI DNLSQNGEGR ISVSHVGSTA SKNSNLNVCN VCLGILQEFC
121 EKDFIKKVCQ KVEASGFEFT SLVFSVSFPP QLSVREHAAW LLVKQEMGKQ SLSLGRDDIV
181 QLKEAYKWIT HPLFSEELGV PIDGKSLFEV SVVFAHPETV EDCHFLAAIC PDCFKPAKNK
241 QSVFTRMAVM KALNKIKEED FLKQFPCPPN SPKAVCAVLE IECAHGAVFV AGRYNKYSRN
301 LPQTPWIIDG ERKLESSVEE LISDHLLAVF KAESFNFSSS GREDVDVRTL GNGRPFAIEL
361 VNPHRVHFTS QEIKELQQKI NNSSNKIQVR DLQLVTREAI GHMKEGEEEK TKTYSALIWT
421 NKAIQKKDIE FLNDIKDLKI DQKTPLRVLH RRPLAVRARV IHFMETQYVD EHHFRLHLKT
481 QAGTYIKEFV HGDFGRTKPN IGSLMNVTAD ILELDVESVD VDWPPALDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PUS10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- liver: 14 nTPM
- small intestine: 8.7 nTPM
- duodenum: 7.1 nTPM
- thyroid gland: 6.4 nTPM
- tonsil: 6.4 nTPM
- lymph node: 6.3 nTPM
Single-cell type
- epicardial cells: 296 nCPM
- cardiomyocytes: 96 nCPM
- myonuclei: 93 nCPM
- enterocytes: 70 nCPM
- adipocytes: 56 nCPM
- alveolar cells type 2: 53 nCPM
Immune cell
- basophil: 9.1 nTPM
- non-classical monocyte: 4.8 nTPM
- NK-cell: 3.1 nTPM
- memory B-cell: 3 nTPM
- plasmacytoid DC: 2.9 nTPM
- MAIT T-cell: 2.5 nTPM
Brain region
- white matter: 7.3 nTPM
- choroid plexus: 6.8 nTPM
- spinal cord: 6.4 nTPM
- thalamus: 6.4 nTPM
- medulla oblongata: 6.3 nTPM
- cerebral cortex: 6.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.04
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- metal ion binding
- primary miRNA binding
- pseudouridine synthase activity
- tRNA pseudouridine synthase activity
- tRNA pseudouridine(55) synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pseudouridine synthase, catalytic domain superfamily
- tRNA pseudouridine synthase Pus10-like
- Pus10-like, C-terminal
- Pus10, N-terminal, eukaryotes
- Eukaryotic Pus10, N-terminal
- Pus10, C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PUS10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PUS10 as an antibody target. Whether an autoantibody or antibody against PUS10 could matter depends on whether native PUS10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PUS10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PUS10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...